New frontiers in CRISPR: Addressing antimicrobial resistance with Cas9, Cas12, Cas13, and Cas14
Background: The issue of antimicrobial resistance (AMR) poses a major challenge to global health, evidenced by alarming mortality predictions and the diminishing efficiency of conventional antimicrobial drugs. The CRISPR-Cas system has proven to be a powerful tool in addressing this challenge. It or...
Saved in:
Main Authors: | Ahmed S.A. Ali Agha, Ali Al-Samydai, Talal Aburjai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025003937 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR/Cas Enzyme Catalysis in Liquid–Liquid Phase‐Separated Systems
by: Yaqin Zhang, et al.
Published: (2025-01-01) -
A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
by: Akram Hosen, et al.
Published: (2025-01-01) -
CRISPR/Cas9: Role of genome editing in cancer immunotherapy
by: S. Vimal, et al.
Published: (2024-06-01) -
Exploiting CRISPR/Cas system in controlling antibiotic resistance of bacteria
by: Pourya Gholizadeh, et al.
Published: (2024-07-01) -
Genome editing using CRISPR/ Cas9 system: a practical guide
by: A. G. Menzorov, et al.
Published: (2017-02-01)